Pfizer CEO Says Science Will Prevail With Covid-19 Here to Stay
Albert Bourla talks about having the tools to manage the virus as we do the seasonal flu, the new variants, and the difference between the Trump and Biden administrations
By John Micklethwait
In an interview with Bloomberg Editor-in-Chief John Micklethwait, one of the people most responsible for helping to vaccinate the world against Covid-19 discusses how his company is navigating the pandemic.
JOHN MICKLETHWAIT: How frightened should we be about the new coronavirus variants?
ALBERT BOURLA: We should not be frightened, but we need to be prepared. So we are focusing right now on having a very good surveillance network, so every time that the new variant comes up, we should be able to test, at least in the labs, if the vaccine is effective or not.
Way back, we had discussed the possibility that a variant would arise for which the vaccine would not provide protection. And we were working on a process that will allow us to do the development very fast. Now we have started implementing this process.
